|
[Related PubMed/MEDLINE] Total Number of Papers: 112
|
|
|
[Display Entries]
|
>> all entries
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2023 |
Brazilian red propolis in combination with β-lactams exerts an efficient antibacterial action over methicillin-resistant Staphylococcus aureus (MRSA) strains. |
BPE, CEFO, ERTA, IMI, MRSA, RPE |
2 |
2022 |
Molecular Basis of Non-beta-Lactam Antibiotics Resistance in Staphylococcus aureus. |
MRSA |
3 |
2022 |
Molecular docking and proteomics reveals the synergistic antibacterial mechanism of theaflavin with beta-lactam antibiotics against MRSA. |
FICI, S. aureus, TF |
4 |
2022 |
Targeted inhibition of methicillin-resistant Staphylococcus aureus biofilm formation by a graphene oxide-loaded aptamer/berberine bifunctional complex. |
agr, GO, MRSA, SELEX |
5 |
2021 |
Accumulation of Succinyl Coenzyme A Perturbs the Methicillin-Resistant Staphylococcus aureus (MRSA) Succinylome and Is Associated with Increased Susceptibility to Beta-Lactam Antibiotics. |
Atl, MRSA, succinyl-CoA, TCA |
6 |
2021 |
Design, synthesis of pyridine coupled pyrimidinone/pyrimidinthione as anti-MRSA agent: Validation by molecular docking and dynamics simulation. |
MRSA |
7 |
2021 |
Discovery of novel Staphylococcus aureus penicillin binding protein 2a inhibitors by multistep virtual screening and biological evaluation. |
MD, MRSA, SPR |
8 |
2021 |
Improved Detection of mecA-Mediated beta-Lactam Resistance in Staphylococcus lugdunensis Using a New Oxacillin Salt Agar Screen. |
CA, DD |
9 |
2021 |
Mutation-Based Antibiotic Resistance Mechanism in Methicillin-Resistant Staphylococcus aureus Clinical Isolates. |
MRSA |
10 |
2021 |
Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein. |
MRSA, MS |
11 |
2021 |
Study on Demethoxycurcumin as a Promising Approach to Reverse Methicillin-Resistance of Staphylococcus aureus. |
DMC, MICs, MRSA |
12 |
2020 |
Eleutheroside K isolated from Acanthopanax henryi (Oliv.) Harms suppresses methicillin resistance of Staphylococcus aureus. |
ETSK, MIC, Oliv, OXA |
13 |
2020 |
Flavonoids as Potential anti-MRSA Agents through Modulation of PBP2a: A Computational and Experimental Study. |
IVS, MRSA |
14 |
2020 |
Inhibition of penicillin-binding protein 2a (PBP2a) in methicillin resistant Staphylococcus aureus (MRSA) by combination of oxacillin and a bioactive compound from Ramalinaroesleri. |
MICs, MRSA, SEM |
15 |
2020 |
Methicillin-resistant Staphylococcus aureus (MRSA) isolated from raw milk and nasal swabs of small ruminants in Abeokuta, Nigeria. |
MRSA |
16 |
2020 |
The Mechanism of Bisdemethoxycurcumin Enhances Conventional Antibiotics against Methicillin-Resistant Staphylococcus aureus. |
BDMC, MRSA |
17 |
2019 |
Evaluation of disc diffusion tests and agar screening for predicting mecA-mediated oxacillin resistance in Staphylococcus lugdunensis revealed a cefoxitin-susceptible, mecA-positive S. lugdunensis clonal complex 27 clone. |
CA, CLSI, ME, MRSA, S. lugdunensis, VME |
18 |
2019 |
Genomic identification of cryptic susceptibility to penicillins and beta-lactamase inhibitors in methicillin-resistant Staphylococcus aureus. |
MRSA |
19 |
2019 |
Improved Performance of a Rapid Immunochromatographic Assay for Detection of PBP2a in Non-Staphylococcus aureus Staphylococcal Species. |
CI, non-SASS |
20 |
2019 |
Indole-nitroimidazole conjugates as efficient manipulators to decrease the genes expression of methicillin-resistant Staphylococcus aureus. |
DNA, HSA, MRSA |
21 |
2019 |
Label-free detection of nosocomial bacteria using a nanophotonic interferometric biosensor. |
BiMW, LOD, MRSA, MSSA, S/N |
22 |
2019 |
Recombinant PBP2a of methicillin-resistant S. aureus formulation in Alum and Montanide ISA266 adjuvants induced cellular and humoral immune responses with protection in Balb/C mice. |
Ni-NTA |
23 |
2019 |
Tellimagrandin II, A Type of Plant Polyphenol Extracted from Trapa bispinosa Inhibits Antibiotic Resistance of Drug-Resistant Staphylococcus aureus. |
MRSA, TEM, TGII |
24 |
2019 |
The Quinazolinone Allosteric Inhibitor of PBP 2a Synergizes with Piperacillin and Tazobactam against Methicillin-Resistant Staphylococcus aureus. |
MRSA |
25 |
2019 |
[Evaluation of a rapid assay for detection of PBP2a Staphylococcus aureus]. |
MRSA |
26 |
2018 |
Aspermerodione, a novel fungal metabolite with an unusual 2,6-dioxabicyclo[2.2.1]heptane skeleton, as an inhibitor of penicillin-binding protein 2a. |
ECD, MRSA |
27 |
2018 |
Cationic Branched Polyethylenimine (BPEI) Disables Antibiotic Resistance in Methicillin-Resistant Staphylococcus epidermidis (MRSE). |
BPEI, MRSA, MRSE, MRSE, WTA |
28 |
2018 |
Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus. |
MRSA, NPBD, PBD |
29 |
2018 |
Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates. |
CLSI, Ma, Mi, MRSA, PBD, SDD, VM |
30 |
2018 |
Punicalagin suppresses methicillin resistance of Staphylococcus aureus to oxacillin. |
MRSA, PGN |
31 |
2017 |
Antimicrobial activity and synergism of ursolic acid 3-O-alpha-L-arabinopyranoside with oxacillin against methicillin-resistant Staphylococcus aureus. |
MIC, MRSA, OD600, Oliv, OXA, TEM, URS |
32 |
2017 |
BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A beta-Lactamases. |
BLIP-II, MRSA |
33 |
2017 |
Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis. |
--- |
34 |
2017 |
Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study. |
FIC, MRSA |
35 |
2016 |
Improving time to optimal Staphylococcus aureus treatment using a penicillin-binding protein 2a assay. |
--- |
36 |
2016 |
PBP 4 Mediates High-Level Resistance to New-Generation Cephalosporins in Staphylococcus aureus. |
MRSA |
37 |
2016 |
Prevalence of Panton-Valentine leukocidin genes in community-associated methicillin-resistant Staphylococcus aureus in the District of Pomoravlje. |
CA-MRSA, CLSI, PCR, PVL |
38 |
2016 |
Studies on antimicrobial activity of Poncirus trifoliata ethyl extract fraction against methicillin-resistant Staphylococcus aureus and to elucidate its antibacterial mechanism. |
EA08, MIC, MRSA |
39 |
2016 |
The Global Regulon sarA Regulates beta-Lactam Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus In Vitro and in Endovascular Infections. |
MRSA |
40 |
2015 |
Evaluation of an Immunochromatographic Assay for Rapid Detection of Penicillin-Binding Protein 2a in Human and Animal Staphylococcus intermedius Group, Staphylococcus lugdunensis, and Staphylococcus schleiferi Clinical Isolates. |
--- |
41 |
2015 |
In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program. |
AWARE, MRSA, ST5 |
42 |
2015 |
Inhibition of penicillin-binding protein 2a (PBP2a) in methicillin resistant Staphylococcus aureus (MRSA) by combination of ampicillin and a bioactive fraction from Duabanga grandiflora. |
HPLC, MIC, MRSA |
43 |
2015 |
Inhibitory effect of Duabanga grandiflora on MRSA biofilm formation via prevention of cell-surface attachment and PBP2a production. |
MRSA |
44 |
2015 |
Old Drugs To Treat Resistant Bugs: Methicillin-Resistant Staphylococcus aureus Isolates with mecC Are Susceptible to a Combination of Penicillin and Clavulanic Acid. |
blaZLGA251, MRSA, SCCmec |
45 |
2015 |
Prevention of cell-surface attachment and reduction of penicillin-binding protein 2a (PBP2a) level in methicillin-resistant Staphylococcus aureus biofilms by Acalypha wilkesiana. |
HPLC, MRSA |
46 |
2015 |
Synergistic, collaterally sensitive beta-lactam combinations suppress resistance in MRSA. |
MRSA |
47 |
2015 |
The Allosteric Site for the Nascent Cell Wall in Penicillin-Binding Protein 2a: An Achilles' Heel of Methicillin-Resistant Staphylococcus aureus. |
MRSA |
48 |
2015 |
The Association of Panton-Valentine leukocidin and mecA Genes in Methicillin-Resistant Staphylococcus aureus Isolates From Patients Referred to Educational Hospitals in Ahvaz, Iran. |
MRSA, PVL |
49 |
2014 |
Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective. |
MRSA |
50 |
2014 |
beta-Lactam resistance in methicillin-resistant Staphylococcus aureus USA300 is increased by inactivation of the ClpXP protease. |
CA, MRSA |
51 |
2014 |
Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance. |
HeR, HoR, MRSA |
52 |
2014 |
Development of an immunoaffinity solid phase microextraction method for the identification of penicillin binding protein 2a. |
BSA, MRSA, SPME |
53 |
2014 |
Discovery of a new class of non-beta-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity. |
MRSA |
54 |
2014 |
Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics. |
MRSA |
55 |
2014 |
PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. |
MRSA |
56 |
2014 |
Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. |
MRSA |
57 |
2014 |
The mecA homolog mecC confers resistance against beta-lactams in Staphylococcus aureus irrespective of the genetic strain background. |
MRSA, SCCmec |
58 |
2014 |
The mechanism of antibacterial activity of phlorofucofuroeckol-A against methicillin-resistant Staphylococcus aureus. |
MRSA, PFF |
59 |
2013 |
Cloning, Expression and Purification of Penicillin Binding Protein2a (PBP2a) from Methicillin Resistant Staphylococcus aureus: A Study on Immunoreactivity in Balb/C Mouse. |
IPTG, S. aureus |
60 |
2013 |
Evaluation and use of a rapid Staphylococcus aureus assay by an antimicrobial stewardship program. |
MRSA, MSSA |
61 |
2013 |
How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. |
MRSA, PBPs |
62 |
2013 |
The differential detection of methicillin-resistant, methicillin-susceptible and borderline oxacillin-resistant Staphylococcus aureus by surface plasmon resonance. |
BORSA, MRSA, MSSA |
63 |
2013 |
Wound infections caused by inducible meticillin-resistant Staphylococcus aureus strains. |
MRSA |
64 |
2012 |
Analysis of borderline oxacillin-resistant Staphylococcus aureus (BORSA) strains isolated in Tunisia. |
BORSA |
65 |
2012 |
Ceftaroline in complicated skin and skin-structure infections. |
cSSSIs, MRSA |
66 |
2012 |
Community-acquired methicillin-resistant Staphylococcus aureus from skin and soft tissue infections (in a sample of Egyptian population): analysis of mec gene and staphylococcal cassette chromosome. |
CA-MRSA, HA-MRSA, PVL, SCCmec, SSTIs |
67 |
2012 |
Evaluation of Clearview Exact PBP2a, a new immunochromatographic assay, for detection of low-level methicillin-resistant Staphylococcus aureus (LL-MRSA). |
ICA, LL-MRSA |
68 |
2012 |
Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections. |
HeR, MSSA, PIA/PNAG |
69 |
2011 |
Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin. |
MRSA |
70 |
2011 |
Computational studies of bacterial resistance to beta-lactam antibiotics: mechanism of covalent inhibition of the penicillin-binding protein 2a (PBP2a). |
MRSA |
71 |
2011 |
Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. |
CC130, ccr, DRs, MRSA, ORFs, SCCmec, SCCmec XI |
72 |
2011 |
Genotypic relatedness and phenotypic characterization of Staphylococcus schleiferi subspecies in clinical samples from dogs. |
PFGE |
73 |
2011 |
Microtiter plate-based assay for inhibitors of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus. |
MRSA |
74 |
2010 |
Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillin-binding protein (PBP) 2a-mediated beta-lactam resistance by delocalizing PBP2. |
CM, ECg, MRSA, PBP |
75 |
2008 |
Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics. |
MRSA |
76 |
2008 |
In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus. |
BPR, MRSA |
77 |
2007 |
Characterization of the beta-lactam antibiotic sensor domain of the MecR1 signal sensor/transducer protein from methicillin-resistant Staphylococcus aureus. |
MRSA |
78 |
2007 |
Surveillance of healthy cats and cats with inflammatory skin disease for colonization of the skin by methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi ssp. schleiferi. |
ISD, MR, PCR, PFGE, SCCmec |
79 |
2007 |
[Clone, expression and identification of penicillin binding protein 2a of methicillin-resistant Staphylococcus aureus isolated from patients]. |
IPTG, MRSA |
80 |
2007 |
[Preparation, characterization and preliminary application of monoclonal antibody against the transpeptidase domain of MRSA-PBP2a]. |
mAb |
81 |
2005 |
Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. |
MRSA |
82 |
2005 |
Correlation of penicillin Binding protein 2a detection with oxacillin resistance in Staphylococcus aureus and discovery of a novel penicillin binding protein 2a mutation. |
LAT |
83 |
2004 |
Evaluation of penicillin binding protein 2a latex agglutination assay for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures. |
--- |
84 |
2004 |
LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus. |
MRSA |
85 |
2004 |
Methicillin resistance of staphylococci isolated from the skin of dogs with pyoderma. |
PCR |
86 |
2004 |
The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. |
MRSA |
87 |
2003 |
A novel strategy for in vitro selection of peptide-drug conjugates. |
--- |
88 |
2003 |
Rapid MRSA detection by a latex kit. |
MRSA, MSSA |
89 |
2003 |
Resistance to beta-lactam antibiotics and its mediation by the sensor domain of the transmembrane BlaR signaling pathway in Staphylococcus aureus. |
BlaR |
90 |
2003 |
RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases. |
MRSA, MSSA |
91 |
2002 |
Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in Central Sydney, Australia. |
MDR, MRSA, NMDR |
92 |
2002 |
Detection of methicillin and mupirocin resistance in Staphylococcus aureus isolates using conventional and molecular methods: a descriptive study from a burns unit with high prevalence of MRSA. |
MIC, MRSA, PCR |
93 |
2002 |
Detection of methicillin resistance in primary blood culture isolates of coagulase-negative staphylococci by PCR, slide agglutination, disk diffusion, and a commercial method. |
LA |
94 |
2002 |
Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. |
MRSA |
95 |
2000 |
Evaluation of a latex agglutination assay for rapid detection of oxacillin resistant Staphylococcus aureus. |
LA, PCR |
96 |
2000 |
Identification and characterization of the penicillin-binding protein 2a of Streptococcus pneumoniae and its possible role in resistance to beta-lactam antibiotics. |
--- |
97 |
1999 |
Penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: kinetic characterization of its interactions with beta-lactams using electrospray mass spectrometry. |
MRSA |
98 |
1999 |
Rapid detection of methicillin resistance in Staphylococcus aureus isolates by the MRSA-screen latex agglutination test. |
MRSA |
99 |
1998 |
Identification of the active site serine of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by electrospray mass spectrometry. |
LC/MS, MRSA |
100 |
1998 |
Soluble penicillin-binding protein 2a: beta-lactam binding and inhibition by non-beta-lactams using a 96-well format. |
--- |
|